162 related articles for article (PubMed ID: 10462366)
1. Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis.
Ackermann D; Vogt B; Escher G; Dick B; Reichen J; Frey BM; Frey FJ
Hepatology; 1999 Sep; 30(3):623-9. PubMed ID: 10462366
[TBL] [Abstract][Full Text] [Related]
2. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.
Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ
J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210
[TBL] [Abstract][Full Text] [Related]
3. Reduced 11beta-hydroxysteroid dehydrogenase activity in experimental nephrotic syndrome.
Vogt B; Dick B; Marti HP; Frey FJ; Frey BM
Nephrol Dial Transplant; 2002 May; 17(5):753-8. PubMed ID: 11981059
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
Sewell KJ; Shirley DG; Michael AE; Thompson A; Norgate DP; Unwin RJ
Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone enhances 11beta-hydroxysteroid dehydrogenase type 2 expression in colonic epithelial cells in vivo.
Fukushima K; Funayama Y; Yonezawa H; Takahashi K; Haneda S; Suzuki T; Sasano H; Naito H; Shibata C; Krozowski ZS; Sasaki I
Scand J Gastroenterol; 2005 Jul; 40(7):850-7. PubMed ID: 16109662
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
Ricketts ML; Stewart PM
Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
[TBL] [Abstract][Full Text] [Related]
7. In vivo inhibition of renal 11beta-hydroxysteroid dehydrogenase in the rat stimulates collecting duct sodium reabsorption.
Bailey MA; Unwin RJ; Shirley DG
Clin Sci (Lond); 2001 Aug; 101(2):195-8. PubMed ID: 11473496
[TBL] [Abstract][Full Text] [Related]
8. Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis.
Quattropani C; Vogt B; Odermatt A; Dick B; Frey BM; Frey FJ
J Clin Invest; 2001 Nov; 108(9):1299-305. PubMed ID: 11696574
[TBL] [Abstract][Full Text] [Related]
9. Adrenal gland involvement in the regulation of renal 11beta-hydroxysteroid dehydrogenase 2.
Zallocchi ML; Matkovic L; Calvo JC; Damasco MC
J Cell Biochem; 2004 Jun; 92(3):591-602. PubMed ID: 15156570
[TBL] [Abstract][Full Text] [Related]
10. Effect of chenodeoxycholic acid on 11beta-hydroxysteroid dehydrogenase in various target tissues.
Morris DJ; Souness GW; Latif SA; Hardy MP; Brem AS
Metabolism; 2004 Jun; 53(6):811-6. PubMed ID: 15164334
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
[TBL] [Abstract][Full Text] [Related]
12. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
Latif SA; Pardo HA; Hardy MP; Morris DJ
Mol Cell Endocrinol; 2005 Nov; 243(1-2):43-50. PubMed ID: 16188377
[TBL] [Abstract][Full Text] [Related]
13. Regulation of 11 beta-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol.
Gomez-Sanchez EP; Ganjam V; Chen YJ; Liu Y; Zhou MY; Toroslu C; Romero DG; Hughson MD; de Rodriguez A; Gomez-Sanchez CE
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E272-9. PubMed ID: 12700160
[TBL] [Abstract][Full Text] [Related]
14. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.
Bistrup C; Thiesson HC; Jensen BL; Skøtt O
Acta Physiol Scand; 2005 Jun; 184(2):161-9. PubMed ID: 15916676
[TBL] [Abstract][Full Text] [Related]
15. Furosemide inhibits 11beta-hydroxysteroid dehydrogenase type 2.
Fuster D; Escher G; Vogt B; Ackermann D; Dick B; Frey BM; Frey FJ
Endocrinology; 1998 Sep; 139(9):3849-54. PubMed ID: 9724039
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids and 11 beta-hydroxysteroid dehydrogenase type 2 gene expression in the aging kidney.
Audigé A; Dick B; Frey BM; Frey FJ; Corman B; Vogt B
Eur J Clin Invest; 2002 Jun; 32(6):411-20. PubMed ID: 12059986
[TBL] [Abstract][Full Text] [Related]
17. Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor.
Stauffer AT; Rochat MK; Dick B; Frey FJ; Odermatt A
J Biol Chem; 2002 Jul; 277(29):26286-92. PubMed ID: 12015312
[TBL] [Abstract][Full Text] [Related]
18. Effects of spironolactone on systolic blood pressure in experimental diabetic rats.
Liu YJ; Nakagawa Y; Toya K; Wang Y; Saegusa H; Nakanishi T; Ohzeki T
Kidney Int; 2000 May; 57(5):2064-71. PubMed ID: 10792625
[TBL] [Abstract][Full Text] [Related]
19. Extracellular ATP determines 11beta-hydroxysteroid dehydrogenase type 2 activity via purinergic receptors.
Kadereit B; Fustier P; Shojaati K; Frey BM; Frey FJ; Mohaupt MG
J Am Soc Nephrol; 2005 Dec; 16(12):3507-16. PubMed ID: 16251242
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenase 2 in human gastric mucosa.
Kato K; Sasano H; Ohara S; Sekine H; Mochizuki S; Mune T; Yasuda K; Nagura H; Shimosegawa T; Toyota T; Krozowski Z
J Clin Endocrinol Metab; 1999 Jul; 84(7):2568-73. PubMed ID: 10404838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
